Evotec (EVO)
(Delayed Data from NSDQ)
$5.02 USD
-0.08 (-1.57%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $5.00 -0.02 (-0.40%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth D Momentum C VGM
Income Statements
Fiscal Year end for Evotec AG falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | NA | 792 | 731 | 572 | 500 |
Cost Of Goods | NA | 608 | 552 | 429 | 351 |
Gross Profit | NA | 183 | 179 | 144 | 149 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 161 | 131 | 88 | 79 |
Income After Depreciation & Amortization | 0 | 22 | 49 | 55 | 70 |
Non-Operating Income | NA | -170 | 243 | -16 | 2 |
Interest Expense | NA | 14 | 11 | 10 | 8 |
Pretax Income | NA | -162 | 280 | 29 | 63 |
Income Taxes | NA | 23 | 25 | 22 | 22 |
Minority Interest | NA | 0 | 0 | 0 | -1 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | -185 | 255 | 7 | 42 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | -185 | 255 | 7 | 43 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 110 | 132 | 120 | 126 |
Depreciation & Amortization (Cash Flow) | NA | 88 | 83 | 64 | 56 |
Income After Depreciation & Amortization | 0 | 22 | 49 | 55 | 70 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | 312.60 | 304.58 |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | 0.02 | 0.14 |
Diluted Net EPS (GAAP) | NA | -0.52 | 0.77 | 0.02 | 0.14 |
Fiscal Year end for Evotec AG falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | NA | 213.63 | 185.67 | NA |
Cost Of Goods | NA | NA | 172.46 | 135.16 | NA |
Gross Profit | NA | NA | 41.17 | 50.51 | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 54.43 | 90.08 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | -13.26 | -39.57 | 0.00 |
Non-Operating Income | NA | NA | -15.46 | 20.05 | NA |
Interest Expense | NA | NA | 3.83 | 2.77 | NA |
Pretax Income | NA | NA | -32.56 | -22.28 | NA |
Income Taxes | NA | NA | 9.84 | -6.01 | NA |
Minority Interest | NA | NA | 0.00 | 0.00 | NA |
Investment Gains/Losses | NA | NA | 0.00 | 0.00 | NA |
Other Income/Charges | NA | NA | 0.00 | 0.00 | NA |
Income From Cont. Operations | NA | NA | -42.40 | -16.28 | NA |
Extras & Discontinued Operations | NA | NA | 0.00 | 0.00 | NA |
Net Income (GAAP) | NA | NA | -42.40 | -16.28 | NA |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | NA | -0.48 | -0.17 | NA |